Gulf International Bank (UK)’s Neurocrine Biosciences NBIX Stock Holding History

Gulf International Bank (UK)’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Buy	7,697 +1,907	+33%	+$253K	0.02%	508
2025 Q4	$821K	Hold	5,790	–	–	0.03%	484
2025 Q3	$813K	Sell	5,790 -160	-3%	-$21.7K	0.03%	486
2025 Q2	$747K	Hold	5,950	–	–	0.03%	493
2025 Q1	$658K	Sell	5,950 -1,745	-23%	-$221K	0.02%	530
2024 Q4	$1.05M	Hold	7,695	–	–	0.03%	476
2024 Q3	$886K	Sell	7,695 -373	-5%	-$51.1K	0.02%	514
2024 Q2	$1.11M	Hold	8,068	–	–	0.03%	463
2024 Q1	$1.11M	Hold	8,068	–	–	0.03%	477
2023 Q4	$1.06M	Sell	8,068 -1,048	-11%	-$121K	0.03%	472
2023 Q3	$1.02M	Sell	9,116 -763	-8%	-$80.3K	0.03%	479
2023 Q2	$931K	Sell	9,879 -2,821	-22%	-$276K	0.02%	540
2023 Q1	$1.28M	Sell	12,700 -720	-5%	-$74.9K	0.03%	514
2022 Q4	$1.6M	Hold	13,420	–	–	0.03%	508
2022 Q3	$1.43M	Hold	13,420	–	–	0.03%	519
2022 Q2	$1.32M	Hold	13,420	–	–	0.02%	540
2022 Q1	$1.26M	Hold	13,420	–	–	0.02%	568
2021 Q4	$1.14M	Hold	13,420	–	–	0.02%	592
2021 Q3	$1.29M	Hold	13,420	–	–	0.02%	608
2021 Q2	$1.31M	Hold	13,420	–	–	0.02%	619
2021 Q1	$1.3M	Sell	13,420 -6,300	-32%	-$661K	0.02%	607
2020 Q4	$1.89M	Sell	19,720 -200	-1%	-$19.3K	0.02%	561
2020 Q3	$1.92M	Hold	19,920	–	–	0.03%	503
2020 Q2	$2.43M	Hold	19,920	–	–	0.04%	434
2020 Q1	$1.72M	Hold	19,920	–	–	0.03%	456
2019 Q4	$2.14M	Buy	+19,920	New	+$2.09M	0.03%	496

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gulf International Bank (UK)'s NBIX Position: Q1 2026 in Review

Gulf International Bank (UK) increased its Neurocrine Biosciences (NBIX) stake by 33% in Q1 2026, buying an estimated $253K and bringing the position to 7,697 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #508.

Gulf International Bank (UK) first reported a position in NBIX in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.43M in Q2 2020. 696 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

Gulf International Bank (UK) held 7,697 shares of Neurocrine Biosciences worth $1.01M as of Q1 2026.
Gulf International Bank (UK) bought 1,907 Neurocrine Biosciences shares in Q1 2026, an estimated $253K.
Neurocrine Biosciences made up 0.02% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #508 holding.
Gulf International Bank (UK) first reported a position in Neurocrine Biosciences in Q4 2019 and has held it in 26 quarters since.
Gulf International Bank (UK)'s Neurocrine Biosciences position peaked at $2.43M in Q2 2020.
696 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.